Atripla Side Effects

Dizziness, fatigue, nausea, and diarrhea are the most commonly reported side effects of Atripla. Those that are not as common (occurring in 1 to 4 percent of people) include sore throat and runny nose, vomiting, and drowsiness. In most cases, Atripla side effects are minor and easily treated, but you should seek medical attention immediately if you develop kidney problems, suicidal thoughts, or anxiety.

 

Atripla Side Effects: An Introduction

As with any medicine, side effects are possible with Atripla™ (efavirenz, emtricitabine, and tenofovir disoproxil fumarate); however, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with Atripla. Your healthcare provider can discuss a more complete list of Atripla side effects with you.)
 

Common Atripla Side Effects

Atripla has been studied thoroughly in clinical trials. In these studies, the side effects that occur in a group of people taking the drug are documented and are then compared to side effects that occur in another group of people not taking the medicine. This way, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the medicine.
 
In these studies, the most common Atripla side effects included:
 
  • Nausea -- in up to 8 percent of people
  • Dizziness -- up to 8 percent
  • Diarrhea -- up to 7 percent
  • Fatigue -- up to 7 percent
  • Headaches -- up to 5 percent.
     
Other common side effects (occurring in 1 to 4 percent of people) included:
 
  • Upper respiratory tract infection (such as the common cold)
  • Sore throat and runny nose
  • Vomiting
  • Sinus infection
  • Drowsiness
  • Abnormal dreams.
     
(Atripla Side Effects Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;